2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$4.52+$0.08 (+1.82%)
Price as of Oct 02, 2026 6:25 PM EDT- $557.3MMarket Cap
- -23.05%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$4.52+$0.08 (+1.82%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.44 | ||
Change | -$0.19 (-4.10%) | ||
Open | $4.60 | ||
High | $4.61 | ||
Low | $4.43 | ||
Previous Close | $4.63 | ||
Volume | 2,686,549 | ||
30-Day Average Volume | 2,301,311 | ||
1-Week Change | -7.88% | ||
1-Month Change | -15.27% | ||
1-Year Change | -23.05% | ||
3-Year Change | 190.20% | ||
5-Year Change | 3.98% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $132.1M | ||
Market Cap | $557.3M | ||
Enterprise Value | $509.5M | ||
Period: QTR TTM FY | |||
Revenue | $13.8M | ||
Net Income | -$22.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$22.9M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $102.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 37 | ||
P/B | -10 | ||
P/E | -25 | ||
PEG | 0 | ||
Price/Free Cash Flow | -58 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue